CUE: Meluzio Michael Vincent sold $32K of stock
By AlphaYouPublished Form 4
Meluzio Michael Vincent
Reporting filer
Meluzio Michael Vincent reported selling 1,144 shares of Cue Biopharma, Inc. for about $32K ($28.05 a share on average). Form 4 filed Oct 15, 2026 lists 1 entry.
See the price move since this trade →
- Disclosed
- Oct 15, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Meluzio Michael Vincent | 2026-10-12 | S | Sale | 1144 | 28.05 | 47,817 | 3 days | Filed terms
|
Common Stock
- Owner
- Meluzio Michael Vincent
- Date
- 2026-10-12
- Code
- S
- Action
- Sale
- Quantity
- 1144
- Price
- 28.05
- Following holdings
- 47,817
- Reporting delay
- 3 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-12
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- id: F1
- transaction Shares: 1144
- transaction Price Per Share: 28.05
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 47817
- direct Or Indirect Ownership: D
- nature Of Ownership:
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Meluzio Michael Vincent: VP, Prin. Accounting Officer.
- F1: The sales reported represent shares sold pursuant to the Issuer's Company-Wide Policy and do not represent discretionary transactions by the Reporting Person. These sales were made automatically to satisfy mandatory tax withholding obligations through a "sell-to-cover" transaction in connection with the vesting and settlement of restricted stock units, and the Reporting Person did not exercise any control over the timing, price or number of shares sold.
Original sources
Prepared automatically from public filing data. Report a correction.